Holen Sie sich die Stockscreener-App
364.50
0.83%
-3.04
Handel nachbörslich:
364.50
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$367.54
Offen:
$365.51
24-Stunden-Volumen:
1.27M
Relative Volume:
0.96
Marktkapitalisierung:
$142.81B
Einnahmen:
$22.60B
Nettoeinkommen (Verlust:
$2.99B
KGV:
46.97
EPS:
7.76
Netto-Cashflow:
$3.49B
1W Leistung:
-1.78%
1M Leistung:
-6.27%
6M Leistung:
+1.17%
1J Leistung:
+1.85%
1-Tages-Spanne:
$363.27
$368.51
1-Wochen-Bereich:
$359.99
$379.04
52-Wochen-Spanne:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Vergleichen Sie SYK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
364.50 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
ABT
Abbott Laboratories
|
130.82 | 226.88B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.36 | 146.96B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
87.63 | 112.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Stryker Corporation (SYK): Jim Cramer Sees Big Gains Despite Tariff Worries - Insider Monkey
Ex-Dividend Reminder: Stryker, Innovative Industrial Properties and Apple Hospitality REIT - Nasdaq
Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock - Benzinga
Stryker Options Trading: A Deep Dive into Market Sentiment - Benzinga
Stryker increases pay for top execs, reports slightly lower wage for median employee - Medical Design & Outsourcing
Stryker announces intention to nominate Manny Maceda to board of directors - Quantisnow
Stryker nominates new board member - Investing.com
Stryker nominates new board member By Investing.com - Investing.com Canada
Global Transformation Expert and Bain Chairman Joins Stryker's Board - StockTitan
Is It Smart To Buy Stryker Corporation (NYSE:SYK) Before It Goes Ex-Dividend? - Yahoo Finance
Stryker announces Annual Meeting of Shareholders - The Globe and Mail
Here's How Much $1000 Invested In Stryker 5 Years Ago Would Be Worth Today - Benzinga
What's Driving the Market Sentiment Around Stryker? - Benzinga
Breaking Down Stryker: 13 Analysts Share Their Views - Benzinga
Needham maintains Stryker stock Buy rating, $442 target - Investing.com
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec - Yahoo Finance
New Jersey Rep. Thomas Kean Sold Over $17K Worth of Stryker Stock: Here's What You Should Know - Benzinga
Stryker : 2024 Comprehensive Report Factsheet -March 17, 2025 at 08:10 am EDT - Marketscreener.com
Thomas Kean Jr makes notable trades in Amazon, Magnera Corp, and Stryker Corp - Investing.com Australia
Spelman College Receives $30M To Help Fund New Arts Center - Essence
Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls - MSN
Stryker’s Strong Market Position and Growth Prospects Justify Buy Rating - TipRanks
Stryker Co. (NYSE:SYK) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
RBC Capital maintains Stryker stock Outperform rating, $435 target - Investing.com
RBC Capital maintains Stryker stock Outperform rating, $435 target By Investing.com - Investing.com South Africa
At US$364, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List? - Yahoo Finance
Stryker Rides Wave as New Products See Continued Adoption - Morningstar
Piper Sandler maintains $420 target on Stryker stock - Investing.com
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting - Quantisnow
Revolutionary Upgrade: How Stryker's New Mako Robot Transforms 4 Major Surgeries - StockTitan
Stryker Stock To $300? - Nasdaq
Stryker Corp (SYK) Unveils Artix Thrombectomy System for Enhanced Arterial Clot Treatment - GuruFocus.com
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases - Marketscreener.com
StockNews.com Downgrades Stryker (NYSE:SYK) to Hold - Defense World
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio - Yahoo Finance
Is Stryker Stock Outperforming the S&P 500? - Nasdaq
Is Stryker Stock Outperforming The S&P 500? - Barchart
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge - Yahoo Finance
Global Operating Room Equipment Market is Predicted to Cross ~USD 40 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Stryker (NYSE:SYK) Unveils Steri-Shield 8 With Advanced PPE Features For Healthcare Professionals - Yahoo Finance
Goldman Sachs Adjusts Price Target on Stryker to $422 From $427 -March 04, 2025 at 09:11 am EST - Marketscreener.com
Stryker unveils new Steri-Shield 8 PPE system - Investing.com
Stryker launches Steri-Shield 8 personal protection system -March 04, 2025 at 08:08 am EST - Marketscreener.com
Stryker launches Steri-Shield 8 personal protection system – Company Announcement - Financial Times
Here's How Much $100 Invested In Stryker 15 Years Ago Would Be Worth Today - Benzinga
Stryker unveils wearable device for care team communication - Investing.com
Stryker launches Sync Badge -March 03, 2025 at 08:08 am EST - Marketscreener.com
Stryker Launches Sync Badge - Barchart
Stryker launches Sync Badge -March 03, 2025 at 08:07 am EST - Marketscreener.com
How Stryker's New Wearable Tech Could Transform Hospital Communication During Staff Shortages - StockTitan
Stryker Co. (NYSE:SYK) is Davis Rea LTD.'s 8th Largest Position - MarketBeat
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Stryker Corp-Aktie (SYK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pierce James Andrew | Group President |
Mar 21 '25 |
Option Exercise |
0.00 |
314 |
0 |
72,561 |
| Menon Viju | Group President |
Mar 21 '25 |
Option Exercise |
0.00 |
187 |
0 |
16,934 |
| Lobo Kevin | Chair and CEO |
Mar 21 '25 |
Option Exercise |
0.00 |
1,085 |
0 |
145,625 |
| Fletcher Robert S | VP, Chief Legal Officer |
Mar 21 '25 |
Option Exercise |
0.00 |
144 |
0 |
15,261 |
| Fink M Kathryn | VP, Chief HR Officer |
Mar 21 '25 |
Option Exercise |
0.00 |
102 |
0 |
14,157 |
| Boehnlein Glenn S | VP, Chief Financial Officer |
Mar 21 '25 |
Option Exercise |
0.00 |
314 |
0 |
18,358 |
| Becker Yin C | VP, Chief Corp Affairs Officer |
Mar 21 '25 |
Option Exercise |
0.00 |
42 |
0 |
34,586 |
| Becker Yin C | VP, Chief Corp Affairs Officer |
Feb 27 '25 |
Option Exercise |
96.64 |
4,980 |
481,267 |
35,729 |
| Golston Allan C. | Director |
Feb 18 '25 |
Option Exercise |
122.51 |
3,605 |
441,649 |
18,500 |
| Golston Allan C. | Director |
Feb 18 '25 |
Sale |
383.07 |
2,458 |
941,586 |
14,895 |
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):